Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 4 June 2009, Vol. 113, No. 23, pp. 5829-5838.
Prepublished online as a Blood First Edition Paper on April 3, 2009; DOI 10.1182/blood-2008-09-179507.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2008-09-179507v1
113/23/5829    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dai, J.
Right arrow Articles by Gallagher, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dai, J.
Right arrow Articles by Gallagher, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted September 18, 2008
Accepted March 25, 2009

IFN-{lambda}1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells

Jihong Dai, Nicholas J. Megjugorac, Grant E. Gallagher, Raymond Y.L. Yu, and Grant Gallagher*

Genetic Immunology Laboratory, HUMIGEN, the Institute for Genetic Immunology, Hamilton, NJ, United States

* Corresponding author; email: g.gallagher{at}humigen.org.

IFN-lambda-1 (IFN-{lambda}1/IL-29) plays a novel, emerging role in the inhibition of human Th2 responses. Here, we demonstrate that both naive and memory human CD4+ T cells express mRNA for the IFN-{lambda}1 specific receptor, IL-28R{alpha} and are responsive to IFN-{lambda}1. Expression of Th2 cytokines (IL-4 and IL-13) was suppressed in naive and memory CD4+ T cells by IFN-{lambda}1, without affecting their proliferation. Further, acquisition of IL-4R{alpha} expression following stimulation was inhibited by IFN-{lambda}1, as was GATA3 expression. Finally, IFN-{lambda}1 diminished the change in cell-surface phenotype that accompanies differentiation of "central memory" T cells into "effector memory" T cells. Taken together, our data describe unique immunomodulatory effects of IFN-{lambda}1 and identify novel mechanisms for the reduction of existing Th2 responses and the regulation of new ones, in circulating naive and memory CD4+ T cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
N. J. Megjugorac, G. E. Gallagher, and G. Gallagher
Modulation of human plasmacytoid DC function by IFN-{lambda}1 (IL-29)
J. Leukoc. Biol., December 1, 2009; 86(6): 1359 - 1363.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020